Innoviva Statistics
Total Valuation
Innoviva has a market cap or net worth of $1.62 billion. The enterprise value is $1.41 billion.
| Market Cap | 1.62B |
| Enterprise Value | 1.41B |
Important Dates
The last earnings date was Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Innoviva has 74.77 million shares outstanding. The number of shares has increased by 31.88% in one year.
| Current Share Class | 74.77M |
| Shares Outstanding | 74.77M |
| Shares Change (YoY) | +31.88% |
| Shares Change (QoQ) | +0.61% |
| Owned by Insiders (%) | 0.80% |
| Owned by Institutions (%) | 98.42% |
| Float | 69.57M |
Valuation Ratios
The trailing PE ratio is 14.24 and the forward PE ratio is 10.50. Innoviva's PEG ratio is 0.30.
| PE Ratio | 14.24 |
| Forward PE | 10.50 |
| PS Ratio | 3.59 |
| Forward PS | 3.79 |
| PB Ratio | 1.61 |
| P/TBV Ratio | 2.01 |
| P/FCF Ratio | 8.09 |
| P/OCF Ratio | 8.05 |
| PEG Ratio | 0.30 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.07, with an EV/FCF ratio of 7.05.
| EV / Earnings | 11.10 |
| EV / Sales | 3.64 |
| EV / EBITDA | 7.07 |
| EV / EBIT | 8.14 |
| EV / FCF | 7.05 |
Financial Position
The company has a current ratio of 14.12, with a Debt / Equity ratio of 0.32.
| Current Ratio | 14.12 |
| Quick Ratio | 12.93 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 1.61 |
| Debt / FCF | 1.61 |
| Interest Coverage | 9.58 |
Financial Efficiency
Return on equity (ROE) is 15.17% and return on invested capital (ROIC) is 8.60%.
| Return on Equity (ROE) | 15.17% |
| Return on Assets (ROA) | 8.16% |
| Return on Invested Capital (ROIC) | 8.60% |
| Return on Capital Employed (ROCE) | 12.58% |
| Revenue Per Employee | $3.06M |
| Profits Per Employee | $1.00M |
| Employee Count | 127 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 1.65 |
Taxes
In the past 12 months, Innoviva has paid $29.18 million in taxes.
| Income Tax | 29.18M |
| Effective Tax Rate | 18.64% |
Stock Price Statistics
The stock price has increased by +13.13% in the last 52 weeks. The beta is 0.49, so Innoviva's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +13.13% |
| 50-Day Moving Average | 19.04 |
| 200-Day Moving Average | 19.03 |
| Relative Strength Index (RSI) | 66.94 |
| Average Volume (20 Days) | 938,501 |
Short Selling Information
The latest short interest is 5.47 million, so 7.32% of the outstanding shares have been sold short.
| Short Interest | 5.47M |
| Short Previous Month | 5.18M |
| Short % of Shares Out | 7.32% |
| Short % of Float | 7.87% |
| Short Ratio (days to cover) | 6.61 |
Income Statement
In the last 12 months, Innoviva had revenue of $388.52 million and earned $127.34 million in profits. Earnings per share was $1.52.
| Revenue | 388.52M |
| Gross Profit | 328.46M |
| Operating Income | 173.72M |
| Pretax Income | 156.52M |
| Net Income | 127.34M |
| EBITDA | 200.00M |
| EBIT | 173.72M |
| Earnings Per Share (EPS) | $1.52 |
Balance Sheet
The company has $533.10 million in cash and $323.23 million in debt, giving a net cash position of $209.87 million or $2.81 per share.
| Cash & Cash Equivalents | 533.10M |
| Total Debt | 323.23M |
| Net Cash | 209.87M |
| Net Cash Per Share | $2.81 |
| Equity (Book Value) | 1.01B |
| Book Value Per Share | 13.51 |
| Working Capital | 636.10M |
Cash Flow
In the last 12 months, operating cash flow was $201.66 million and capital expenditures -$1.12 million, giving a free cash flow of $200.54 million.
| Operating Cash Flow | 201.66M |
| Capital Expenditures | -1.12M |
| Free Cash Flow | 200.54M |
| FCF Per Share | $2.68 |
Margins
Gross margin is 84.54%, with operating and profit margins of 44.71% and 32.78%.
| Gross Margin | 84.54% |
| Operating Margin | 44.71% |
| Pretax Margin | 40.29% |
| Profit Margin | 32.78% |
| EBITDA Margin | 51.48% |
| EBIT Margin | 44.71% |
| FCF Margin | 51.61% |
Dividends & Yields
Innoviva does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.88% |
| Shareholder Yield | -31.88% |
| Earnings Yield | 7.85% |
| FCF Yield | 12.35% |
Analyst Forecast
The average price target for Innoviva is $36.60, which is 68.59% higher than the current price. The consensus rating is "Buy".
| Price Target | $36.60 |
| Price Target Difference | 68.59% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 9.91% |
| EPS Growth Forecast (5Y) | 57.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Innoviva has an Altman Z-Score of 3.01 and a Piotroski F-Score of 8.
| Altman Z-Score | 3.01 |
| Piotroski F-Score | 8 |